2025 HCPCS Code C9016
Injection, triptorelin extended release, 3.75 mg
TAGS: triptorelin extendedNotice | HCPCS C9016 terminated on December 31, 2018. |
Short Description | Inj, triptorelin ext rel |
HCPCS Action Code | N - No maintenance for this code |
HCPCS Coverage Code | D - Special coverage instructions apply |
HCPCS Code Added Date | January 01, 2018 |
HCPCS Action Effective Date | January 01, 2019 |
HCPCS Pricing Indicator Code | 53 - Statute |
HCPCS Type Of Service Code | 9 - Other medical items or services |
HCPCS Multiple Pricing Indicator Code | A - Not applicable as HCPCS priced under one methodology |
HCPCS Anesthesia Base Unit Quantity | 0 |
HCPCS Coverage Issues Manual Reference Section Number |
Check Similar HCPCS Codes
- C9051 - Injection, omadacycline
- C9052 - Injection, ravulizumab-cwv
- C9053 - Inj, crizanlizumab-tmca
- C9054 - Injection, lefamulin
- C9055 - Inj, brexanolone
- C9056 - Injection, givosiran
- C9057 - Inj cetirizine hydrochloride
- C9058 - Injection,pegfilgrastim-bmez
- C9059 - Injection, meloxicam
- C9060 - Fluoroestradiol f18
- C9061 - Injection, teprotumumab-trbw
- C9062 - Daratumumab hyaluronidase
- C9063 - Injection, eptinezumab-jjmr
- C9064 - Mitomycin pyelocalyceal inst
- C9065 - Romidepsin non-lyophilized
- C9066 - Sacituzumab govitecan-hziy
- C9067 - Gallium ga-68 dotatoc
- C9068 - Copper cu-64, dotatate, dx
- C9069 - Belantamab mafodontin-blmf
- C9070 - Injection, tafasitamab-cxix